The use of mechanistic DM-PK-PD modelling to assess the power of pharmacogenetic studies -CYP2C9 and warfarin as an example (Q41118521)
Jump to navigation
Jump to search
scientific article published on 12 February 2007
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | The use of mechanistic DM-PK-PD modelling to assess the power of pharmacogenetic studies -CYP2C9 and warfarin as an example |
scientific article published on 12 February 2007 |
Statements
1 reference
The use of mechanistic DM-PK-PD modelling to assess the power of pharmacogenetic studies -CYP2C9 and warfarin as an example (English)
1 reference
Gemma L Dickinson
1 reference
Martin S Lennard
1 reference
Geoffrey T Tucker
1 reference
Amin Rostami-Hodjegan
1 reference
12 February 2007
1 reference
1 reference
64
1 reference
1
1 reference
14-26
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference